JP2001500383A - 結核診断用の化合物および方法 - Google Patents

結核診断用の化合物および方法

Info

Publication number
JP2001500383A
JP2001500383A JP10518432A JP51843298A JP2001500383A JP 2001500383 A JP2001500383 A JP 2001500383A JP 10518432 A JP10518432 A JP 10518432A JP 51843298 A JP51843298 A JP 51843298A JP 2001500383 A JP2001500383 A JP 2001500383A
Authority
JP
Japan
Prior art keywords
seq
polypeptide
antigen
dna sequence
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP10518432A
Other languages
English (en)
Japanese (ja)
Inventor
リード，スティーヴン，ジー．
スケイキー，ヤシール，エー．ダブリュ．
ディロン，ダヴィン，シー．
カンポス―ネト，アントニオ
ホウトン，レイモンド
ヴェドヴィック，トーマス，エス．
トワードジック，ダニエル，アール．
ロッジス，マイケル，ジェイ．
Original Assignee
コリックサ コーポレーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/818,111 external-priority patent/US6338852B1/en
Application filed by コリックサ コーポレーション filed Critical コリックサ コーポレーション
Publication of JP2001500383A publication Critical patent/JP2001500383A/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP10518432A 1996-10-11 1997-10-07 結核診断用の化合物および方法 Ceased JP2001500383A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US72962296A 1996-10-11 1996-10-11
US08/729,622 1996-10-11
US08/818,111 1997-03-13
US08/818,111 US6338852B1 (en) 1995-09-01 1997-03-13 Compounds and methods for diagnosis of tuberculosis
PCT/US1997/018214 WO1998016645A2 (en) 1996-10-11 1997-10-07 Compounds and methods for diagnosis of tuberculosis

Publications (1)

Publication Number Publication Date
JP2001500383A true JP2001500383A (ja) 2001-01-16

Family

ID=27111919

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10518432A Ceased JP2001500383A (ja) 1996-10-11 1997-10-07 結核診断用の化合物および方法

Country Status (11)

Country Link
EP (1) EP0934415A2 (xx)
JP (1) JP2001500383A (xx)
AU (1) AU4750597A (xx)
BR (1) BR9712298A (xx)
CA (1) CA2268036A1 (xx)
CZ (1) CZ126699A3 (xx)
IL (2) IL129389A0 (xx)
NO (1) NO991693L (xx)
PL (1) PL333304A1 (xx)
TR (1) TR199901569T2 (xx)
WO (1) WO1998016645A2 (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009503518A (ja) * 2005-07-26 2009-01-29 ユニヴァーシティ オブ メディシン アンド デンティストリ オブ ニュージャーシィ 結核状態に特有の抗体プロフィール

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US6613881B1 (en) * 1997-05-20 2003-09-02 Corixa Corporation Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
WO1999004005A1 (en) * 1997-07-16 1999-01-28 Institut Pasteur A polynucleotide functionally coding for the lhp protein from mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same
EP1484405A1 (en) * 1997-11-10 2004-12-08 Statens Serum Institut Nucleic acid fragments and polypeptide fragments derived from M. Tuberculosis
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
US20030027774A1 (en) * 1999-03-18 2003-02-06 Ronald C. Hendrickson Tuberculosis antigens and methods of use therefor
EP2087906A1 (en) * 1999-05-04 2009-08-12 The University of Medicine and Dentistry of New Jersey Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines
US7009042B1 (en) 1999-10-07 2006-03-07 Corixa Corporation Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins
EP1517913B9 (en) * 1999-10-07 2007-08-29 Corixa Corporation A mycobacterium tuberculosis coding sequence for exression of heterologous proteins
US6316205B1 (en) 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
AU2001241738A1 (en) 2000-02-25 2001-09-03 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
AU6867801A (en) 2000-06-20 2002-01-02 Corixa Corp Fusion proteins of mycobacterium tuberculosis
US7288261B2 (en) * 2000-07-10 2007-10-30 Colorado State University Research Foundation Mid-life vaccine and methods for boosting anti-mycobacterial immunity
WO2003000721A2 (en) 2001-06-22 2003-01-03 Health Protection Agency Mycobacterial antigens expressed under low oxygen tension
JP2005508613A (ja) 2001-07-04 2005-04-07 ヘルス プロテクション エージェンシー 潜伏中に発現されるマイコバクテリア抗原
TWI243855B (en) * 2001-07-25 2005-11-21 Tosoh Corp Oligonucleotides and process for detecting mycobacterium tuberculosis
GB0125535D0 (en) * 2001-10-24 2001-12-12 Microbiological Res Authority Mycobacterial genes down-regulated during latency
WO2003070187A2 (en) 2002-02-15 2003-08-28 Corixa Corporation Fusion proteins of mycobacterium tuberculosis
US8475735B2 (en) 2004-11-01 2013-07-02 Uma Mahesh Babu Disposable immunodiagnostic test system
WO2006053871A2 (en) 2004-11-16 2006-05-26 Crucell Holland B.V. Multivalent vaccines comprising recombinant viral vectors
CA2821389C (en) 2005-04-29 2015-11-17 Glaxosmithkline Biologicals S.A. Novel method for preventing or treating m tuberculosis infection
CN100999550B (zh) 2006-01-10 2010-10-06 中国人民解放军第三○九医院 结核分枝杆菌融合蛋白及其应用
GB0618127D0 (en) * 2006-09-14 2006-10-25 Isis Innovation Biomarker
WO2008140478A2 (en) 2006-11-01 2008-11-20 Immport Therapeutics, Inc. Compositions and methods for immunodominant antigens
MX2012008790A (es) 2010-01-27 2012-08-17 Glaxosmithkline Biolog Sa Antigenos de tuberculosis modificados.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244539A1 (en) * 1973-07-13 1975-04-18 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
FR2265402A1 (en) * 1974-03-29 1975-10-24 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
EP0419355B1 (en) * 1989-09-19 2000-02-09 N.V. Innogenetics S.A. Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis
FR2677365B1 (fr) * 1991-06-07 1995-08-04 Pasteur Institut Proteines de mycobacterium et applications.
US5330754A (en) * 1992-06-29 1994-07-19 Archana Kapoor Membrane-associated immunogens of mycobacteria
DK79793D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut Diagnostic test
DK79893D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut New vaccine
US5714593A (en) * 1995-02-01 1998-02-03 Institut Pasteur DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton protein
DE69637879D1 (de) * 1995-09-01 2009-04-30 Corixa Corp Verbindungen und Verfahren zur Immuntherapie und Diagnose von Tuberkulose
CN1154730C (zh) * 1995-09-01 2004-06-23 科里克萨有限公司 用于结核病诊断的化合物和方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009503518A (ja) * 2005-07-26 2009-01-29 ユニヴァーシティ オブ メディシン アンド デンティストリ オブ ニュージャーシィ 結核状態に特有の抗体プロフィール

Also Published As

Publication number Publication date
IL129389A0 (en) 2000-02-17
TR199901569T2 (xx) 2000-12-21
NO991693L (no) 1999-06-09
WO1998016645A3 (en) 1998-08-06
PL333304A1 (en) 1999-11-22
AU4750597A (en) 1998-05-11
CZ126699A3 (cs) 1999-09-15
CA2268036A1 (en) 1998-04-23
EP0934415A2 (en) 1999-08-11
IL121936A0 (en) 1998-03-10
NO991693D0 (no) 1999-04-09
BR9712298A (pt) 2000-10-24
WO1998016645A2 (en) 1998-04-23

Similar Documents

Publication Publication Date Title
US7122196B2 (en) Compounds and methods for diagnosis of tuberculosis
EP0850305B1 (en) Compounds and methods for diagnosis of tuberculosis
JP2001500383A (ja) 結核診断用の化合物および方法
US7989605B2 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
US7927609B2 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
EP0851927B1 (en) Compounds for immunotherapy and diagnosis of tuberculosis
CA2290754A1 (en) Compounds for diagnosis of tuberculosis and methods for their use
WO1997009428A9 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
CA2331845A1 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
EP0834567A2 (en) Compounds and methods for the diagnosis and treatment of Babesia microti infection
EP1712629A2 (en) Compounds and methods for diagnosis of tuberculosis
KR20000049100A (ko) 결핵을 진단하는 화합물 및 방법

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20041007

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070130

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20070620

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070731